Botanix Pharmaceuticals Limited
BXPHF
$0.02
$0.007.14%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.39% | 9.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.39% | 9.56% | |||
| Cost of Revenue | 0.39% | 47.13% | |||
| Gross Profit | 0.39% | -11.68% | |||
| SG&A Expenses | 0.39% | 5.75% | |||
| Depreciation & Amortization | 0.39% | -0.39% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.39% | 10.52% | |||
| Operating Income | -0.39% | -11.00% | |||
| Income Before Tax | -0.39% | -15.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.39% | -15.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.39% | -15.19% | |||
| EBIT | -0.39% | -11.00% | |||
| EBITDA | -0.39% | -11.42% | |||
| EPS Basic | 0.00% | 3.64% | |||
| Normalized Basic EPS | 0.00% | 5.71% | |||
| EPS Diluted | 0.00% | 3.64% | |||
| Normalized Diluted EPS | 0.00% | 5.71% | |||
| Average Basic Shares Outstanding | 0.00% | 20.44% | |||
| Average Diluted Shares Outstanding | 0.00% | 20.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||